Efficient removal of colistin A and B in critically ill patients undergoing CVVHDF and sorbent technologies.

CONCLUSIONS: During CPFA-HF and CVVHDF, the extent of colistin removal is high, and patients should receive an unreduced dosage. However, due to risk of accumulation in long-term administration colistin plasma levels determination is recommended.
PMID: 25249467 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)